/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Comparison of Lp(a) assessment in patients with atherosclerotic cardiovascular disease between office-based cardiologists and general practitioners
Event: ESC Congress 2024
Topic: Cardiovascular Risk Assessment
Session: Lp(a) and apoproteins as risk factors
High individual variability in LDL-reductions after inclisiran administration in a "real-world setting"
Event: ESC Congress 2022
Topic: Lipid-Lowering Agents
Session: Lipid-lowering by PCSK9 modulation: what’s new?
Differences in hypercholesterolemia patient management in secondary and primary care: lessons learned from the German PROCYON survey
Event: ESC Congress 2021 - The Digital Experience
Topic: Secondary Prevention
Session: Risk Factors and Prevention ePosters
Markers for cholesterol absorption are associated with In-stent-restenosis after coronary stenting in stable coronary artery disease: An Optical Coherence Tomography study
Event: ESC Congress 2019
Topic: Restenosis
Session: Intracoronary imaging physiology
Low serum lathosterol levels predict fatal cardiovascular disease and all cause mortality: a prospective cohort study in patients admitted for coronary angiography
Event: ESC Congress 2018
Topic: Epidemiology, Prognosis, Outcome
Session: Coronary artery disease - Epidemiology and outcomes
No associations of plasma oxyphytosterol levels and cardiovascular events in patients admitted for coronary angiography
Event: ESC Congress 2018
Topic: Biomarkers
Session: Risk assessment
